GlassScriptPhysician profile
John William Mullens
NPI 1710684428
$2,306.40
in general payments reported to CMS, 2019-2025
23 companies · $797 in 2025
The $797 reported for 2025 was more than what 84% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $427 · 2024: $1,083 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,207 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,207.40 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $275.64 | 2023-2025 | Verquvo, Winrevair |
| Lexicon Pharmaceuticals, INC. | $237.81 | 2023-2024 | Inpefa |
| Cvrx, INC. | $204.56 | 2024-2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $180.56 | 2023-2025 | Farxiga, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.29 | 2023-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $153.99 | 2024 | Opsumit, Uptravi |
| Boston Scientific Corporation | $143.12 | 2024 | Watchman Flx |
| Abiomed | $125.00 | 2025 | |
| Alnylam Pharmaceuticals INC. | $111.50 | 2023-2025 | Amvuttra, Onpattro |
| Kestra Medical Technology Services, INC. | $106.17 | 2023-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.63 | 2024-2025 | Lifevest |
| Pfizer INC. | $81.13 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.95 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $52.78 | 2023-2025 | Camzyos |
| Baxter Healthcare | $45.28 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $43.27 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $39.74 | 2024-2025 | |
| Philips North America LLC | $39.66 | 2025 | Ecc Solutions |
| Novo Nordisk INC | $39.55 | 2023-2024 | Rybelsus, Ozempic |
| Heartflow, INC. | $37.26 | 2025 | |
| Daiichi Sankyo INC. | $24.10 | 2023 | Injectafer |
| Janssen Pharmaceuticals, INC | $23.07 | 2024 | Xarelto |
| United Therapeutics Corporation | $16.34 | 2024 | Tyvaso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mullens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.